Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of BioForte Technology for in Silico Identification of Valuable Genomic Features That Are Candidates for Microbiome-based Therapeutics and Diagnostics.

NCT04136470 is registered in ClinicalTrials.gov with Ardigen as lead sponsor.

NCT NCT04136470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of BioForte Technology for in Silico Identification of Valuable Genomic Features That Are Candidates for Microbiome-based Therapeutics and Diagnostics.
Lead sponsor
Ardigen
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2019
Completion date
March 31, 2021
Enrollment
130 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, melanoma, metagenome, microbiome, non small cell lung cancer